Synergistic activity of co-trimazine and co-trimoxazole in the urine.

Abstract

Co-trimazine (sulphadiazine, 410 mg + trimethoprim, 90 mg) is a new drug combination developed especially for use in the treatment of urinary tract infections. In cross-over experiments in volunteers receiving daily doses of co-trimazine (2 X 500 mg and 1 X 1000 mg), co-trimoxazole (2X960 mg), or nitrofurantoin (3X50 mg), the degree of antibacterial… (More)

Topics

Cite this paper

@article{Acar1979SynergisticAO, title={Synergistic activity of co-trimazine and co-trimoxazole in the urine.}, author={Jale Acar and Britt Inger Ekstr{\"o}m and Hermann Fellner and U Forsgren and J L Guibert and Brownwyn Huitfeldt and Michel Kitzis and Laura R Magni and B Ortengren}, journal={Infection}, year={1979}, volume={7 Suppl 4}, pages={S324-9} }